Rheumatology

Breast Cancer   

Questions discussed in this category


As immune checkpoint inhibitors have expanded into the neoadjuvant breast cancer setting, severe and unexpected autoimmune toxicities may cause delays...

If so, what dose-fractionation do you utilize? What other factors do you take into consideration?

The patient is on a dose of 22 mg of methotrexate weekly for severe rheumatoid arthritis. If you would discontinue the methotrexate, how long would y...

The patient has notable lip lesions from her discoid lupus erythematosus

How does a diagnosis of active RA inform your treatment approach for patients with breast cancer, if at all? 

In a patient with early stage breast cancer that would otherwise require radiation, would you recommend treatment if the patient has active skin lupus...

Do you always stick with a conventional fracionation, or in some cases, are you comfortable hypofractionating? Do you ever use a wait and see approach...

Do you have any concern for increased toxicity when you treat a patient with radiation therapy who has an autoimmune disorder? (hypofractiationation v...


Papers discussed in this category


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997-07

Brachytherapy, 2011

Brachytherapy, 2011

JAMA Netw Open, 2021 Feb 01

Lancet Oncol., 2013-10-01

Arthritis care & research, 2018-10

Breast Care (Basel), 2019 Aug 16